These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21539880)

  • 1. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine.
    Haralambieva IH; Ovsyannikova IG; O'Byrne M; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Jun; 29(27):4485-91. PubMed ID: 21539880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles Virus Neutralizing Antibody Response, Cell-Mediated Immunity, and Immunoglobulin G Antibody Avidity Before and After Receipt of a Third Dose of Measles, Mumps, and Rubella Vaccine in Young Adults.
    Fiebelkorn AP; Coleman LA; Belongia EA; Freeman SK; York D; Bi D; Kulkarni A; Audet S; Mercader S; McGrew M; Hickman CJ; Bellini WJ; Shivakoti R; Griffin DE; Beeler J
    J Infect Dis; 2016 Apr; 213(7):1115-23. PubMed ID: 26597262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.
    Haralambieva IH; Ovsyannikova IG; Kennedy RB; Goergen KM; Grill DE; Chen MH; Hao L; Icenogle J; Poland GA
    Vaccine; 2020 Jan; 38(5):1249-1257. PubMed ID: 31732325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.
    Haralambieva IH; Ovsyannikova IG; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Oct; 29(45):7883-95. PubMed ID: 21875636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine.
    Seagle EE; Bednarczyk RA; Hill T; Fiebelkorn AP; Hickman CJ; Icenogle JP; Belongia EA; McLean HQ
    Vaccine; 2018 Feb; 36(6):818-826. PubMed ID: 29317117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.
    Rasheed MAU; Hickman CJ; McGrew M; Sowers SB; Mercader S; Hopkins A; Grimes V; Yu T; Wrammert J; Mulligan MJ; Bellini WJ; Rota PA; Orenstein WA; Ahmed R; Edupuganti S
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19071-19076. PubMed ID: 31481612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.
    Knuf M; Zepp F; Helm K; Maurer H; Prieler A; Kieninger-Baum D; Douha M; Willems P
    Eur J Pediatr; 2012 Mar; 171(3):463-70. PubMed ID: 21935584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential durability of immune responses to measles and mumps following MMR vaccination.
    Kennedy RB; Ovsyannikova IG; Thomas A; Larrabee BR; Rubin S; Poland GA
    Vaccine; 2019 Mar; 37(13):1775-1784. PubMed ID: 30797639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity.
    Haralambieva IH; Ovsyannikova IG; Vierkant RA; Poland GA
    Clin Vaccine Immunol; 2008 Jul; 15(7):1054-9. PubMed ID: 18463223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
    J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.
    Haralambieva IH; Simon WL; Kennedy RB; Ovsyannikova IG; Warner ND; Grill DE; Poland GA
    Viruses; 2015 Mar; 7(3):1113-33. PubMed ID: 25763865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.
    Berry AA; Abu-Elyazeed R; Diaz-Perez C; Mufson MA; Harrison CJ; Leonardi M; Twiggs JD; Peltier C; Grogg S; Carbayo A; Shapiro S; Povey M; Baccarini C; Innis BL; Henry O
    Hum Vaccin Immunother; 2017 Jul; 13(7):1516-1522. PubMed ID: 28481690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination.
    Dhiman N; Ovsyannikova IG; Ryan JE; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
    Clin Exp Immunol; 2005 Dec; 142(3):498-504. PubMed ID: 16297162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella virus neutralizing antibody response after a third dose of measles-mumps-rubella vaccine in young adults.
    McLean HQ; Fiebelkorn AP; Ogee-Nwankwo A; Hao L; Coleman LA; Adebayo A; Icenogle JP
    Vaccine; 2018 Sep; 36(38):5732-5737. PubMed ID: 30107992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis.
    Latner DR; McGrew M; Williams N; Lowe L; Werman R; Warnock E; Gallagher K; Doyle P; Smole S; Lett S; Cocoros N; DeMaria A; Konomi R; Brown CJ; Rota PA; Bellini WJ; Hickman CJ
    Clin Vaccine Immunol; 2011 Jan; 18(1):35-42. PubMed ID: 21047998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vaccination on measles, mumps, and rubella antibody titers in Japanese healthcare workers: An observational study.
    Ogawa T; Inoue T; Kasahara K; Konishi M; Mikasa K
    PLoS One; 2020; 15(3):e0230329. PubMed ID: 32208432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Durability of humoral immune responses to rubella following MMR vaccination.
    Crooke SN; Riggenbach MM; Ovsyannikova IG; Warner ND; Chen MH; Hao L; Icenogle JP; Poland GA; Kennedy RB
    Vaccine; 2020 Dec; 38(51):8185-8193. PubMed ID: 33190948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.